FDA.reportPublic FDA data

benzocaine 15 MG / menthol 20 MG Oral Lozenge

RxCUI
1923481
RxNorm name
benzocaine 15 MG / menthol 20 MG Oral Lozenge
Display name
Benzocaine/Menthol (Oral Lozenge)
Full name
benzocaine 15 MG / menthol 20 MG Oral Lozenge
Term type
SCD
Status
Active
Strength
15-20 mg
Dose form
Lozenge
Route
Oral Lozenge
Updated
2026-10-27 19:32:31

RxNorm Status History#

Status
Active
Source
RXNORM
Current
YES
Release start
062017
Active start
062017
Multiple ingredient
YES
Branded
NO

Ingredients And Strength#

Ingredient, Strength, Base table
IngredientStrengthBaseBasis of strength
benzocaine15 MG / 1 EACHbenzocainebenzocaine
menthol20 MG / 1 EACHmentholmenthol

Dose Form Concepts#

Dose form, RxCUI table
Dose formRxCUI
Oral Lozenge316992

Derived Ingredient Concepts#

Ingredient, RxCUI table
IngredientRxCUI
benzocaine1399
menthol6750

Source Vocabulary Codes#

Code type, Values, Count table
Code typeValuesCountCategory
PRESCRIBABLEY1ATTRIBUTES
RXNAV_STRbenzocaine 15 MG / menthol 20 MG Oral Lozenge1NAMES
RxNorm Namebenzocaine 15 MG / menthol 20 MG Oral Lozenge1NAMES
TTYSCD1ATTRIBUTES
SPL_SET_ID
2 linked values
2CODES
RxCUI19234811CODES
MMSL_CODE
2 linked values
2CODES

FDA NDC Products And Packages#

Package NDC, Product NDC, Name table
Package NDCProduct NDCNameLabelerApplication
37000-935-1637000-935Vicks VapoCool Benzocaine and MentholThe Procter & Gamble Manufacturing CompanyM022
84126-366-3084126-366Vicks VapoCool Benzocaine and MentholThe Procter & Gamble Manufacturing CompanyM022

Drugs@FDA Applications#

Application, NDC, Name table
ApplicationNDCNameMarketing categoryLabeler
M02237000-935Vicks VapoCool Benzocaine and MentholOTC MONOGRAPH DRUGThe Procter & Gamble Manufacturing Company

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 3 matching rows.

NDC11, Source, Active table
NDC11SourceActive
23900004050rxnav_ndcsyes
37000093516rxnav_ndcsyes
84126036630rxnav_ndcsyes

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 2 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
911a05de-cb3f-c1d2-e053-2995a90ae4bebenzocaine 15 MG / menthol 20 MG Oral Lozenge [PSN] · benzocaine 15 MG / menthol 20 MG Oral Lozenge [SCD]29VICKS ® VapoCOOL™ Sore Throat Lozenges20260323
38cd83db-47ca-e320-e063-6394a90aba41benzocaine 15 MG / menthol 20 MG Oral Lozenge [PSN] · benzocaine 15 MG / menthol 20 MG Oral Lozenge [SCD]21VICKS ® VapoCOOL™ SEVERE + Intense Pain Relief Drops20250630

Recently Linked DailyMed Labels#

Set ID, Title, Manufacturer table
Set IDTitleManufacturerEffective
911a05de-cb3f-c1d2-e053-2995a90ae4beVICKS ® VapoCOOL™ Sore Throat LozengesThe Procter & Gamble Manufacturing Company20261005
38cd83db-47ca-e320-e063-6394a90aba41VICKS ® VapoCOOL™ SEVERE + Intense Pain Relief DropsThe Procter & Gamble Manufacturing Company20261005
911a05de-cb3f-c1d2-e053-2995a90ae4beVICKS ® VapoCOOL™ Sore Throat LozengesThe Procter & Gamble Manufacturing Company20260323
38cd83db-47ca-e320-e063-6394a90aba41VICKS ® VapoCOOL™ SEVERE + Intense Pain Relief DropsThe Procter & Gamble Manufacturing Company20250630

Drug Classes#

Source, Class ID, Class table
SourceClass IDClassTypeRelationshipDrug concept
ATCD04ABAnesthetics for topical useATC1-4benzocaine
ATCR02ADAnesthetics, localATC1-4benzocaine
ATCN01BAEsters of aminobenzoic acidATC1-4benzocaine
ATCC05ADLocal anestheticsATC1-4benzocaine
FDASPLN0000185508Standardized Chemical AllergenEPChas_epcbenzocaine
FDASPLN0000184306Cell-mediated ImmunityPEhas_pebenzocaine
FDASPLN0000175629Increased Histamine ReleasePEhas_pebenzocaine
MEDRTD001566BenzocaineCHEMhas_ingredientbenzocaine
MEDRTD008610MentholCHEMhas_ingredientmenthol
MEDRTD001424Bacterial InfectionsDISEASEci_withbenzocaine
MEDRTD002056BurnsDISEASEmay_treatbenzocaine
MEDRTD004342Drug HypersensitivityDISEASEci_withmenthol
MEDRTD004342Drug HypersensitivityDISEASEci_withbenzocaine
MEDRTD004433EaracheDISEASEmay_treatbenzocaine
MEDRTD005401Fissure in AnoDISEASEmay_treatbenzocaine
MEDRTD006484HemorrhoidsDISEASEmay_treatbenzocaine
MEDRTD006561Herpes SimplexDISEASEmay_treatbenzocaine
MEDRTD019226Oral UlcerDISEASEmay_treatbenzocaine
MEDRTD010032Otitis ExternaDISEASEmay_treatbenzocaine
MEDRTD010033Otitis MediaDISEASEmay_treatbenzocaine
MEDRTD010146PainDISEASEmay_preventbenzocaine
MEDRTD010146PainDISEASEmay_treatmenthol
MEDRTD011537PruritusDISEASEmay_treatbenzocaine
MEDRTD012871Skin DiseasesDISEASEmay_treatmenthol
MEDRTD014098ToothacheDISEASEmay_treatbenzocaine
MEDRTN0000000069Calcium Channel AntagonistsMOAhas_moamenthol
MEDRTN0000000180Sodium Channel InteractionsMOAhas_moabenzocaine
MEDRTN0000008889Decreased Sensory-Somatic Nervous System Organized Electrical ActivityPEhas_pebenzocaine
MEDRTN0000008889Decreased Sensory-Somatic Nervous System Organized Electrical ActivityPEhas_pementhol

Properties#

Category, Property, Value table
CategoryPropertyValue
ATTRIBUTESAVAILABLE_STRENGTH15 MG / 20 MG
ATTRIBUTESGENERAL_CARDINALITYMULTI
ATTRIBUTESHUMAN_DRUGUS
ATTRIBUTESRXNAV_HUMAN_DRUGUS
ATTRIBUTESSCHEDULE0
NAMESPrescribable Synonymbenzocaine 15 MG / menthol 20 MG Oral Lozenge
SOURCESSourceMetathesaurus FDA Structured Product Labels
SOURCESSourceMultum MediSource Lexicon